Delivery Order SPE2DR25D2010-SPE2DR26F5AKD
Award Date 3/6/26
Potential Completion Date 3/9/26
Potential Value $13K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $13,686.82 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for supply of ADDYI (flibanserin) 100 mg tablets in 30-tablet units. Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 10, 2026, and is priced on a firm fixed-price basis. No set-aside was used. The order was issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- The Defense Logistics Agency issued a $14,128 delivery order to AmerisourceBergen Drug Corp on February 3, 2026, for ADDYI (flibansergin) 100 mg tablets, 30-count units, with a ceiling value of $14,128 and ultimate completion date of February 4, 2026. Place of performance is Conshohocken, PA. This is a firm fixed-price delivery order with no set-aside. The order was issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999 through December...
- The Defense Logistics Agency issued a $2,201.85 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for ADDYI 100 mg tablets (30-count units). The order is a firm fixed-price call against the DLA Troop Support Medical Indefinite Delivery Contract SPE2DX, valued at $999,999,999 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order is scheduled for ultimate...
- The Defense Logistics Agency issued a $9,843.14 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for ADDYI 100 mg tablets (30-count units). The order is issued under the parent DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, Pennsylvania. The order has a firm fixed price...
- <p>The Defense Logistics Agency issued a $4,339.09 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for supply of ADDYI 100 mg tablets (flibanserin) under firm fixed-price terms, with ultimate completion by March 9, 2026.</p> <p>Place of performance is Conshohocken, PA. The order carries no set-aside designation and represents a call against the parent Indefinite Delivery Contract with DLA Troop Support Medical.</p>
- The Defense Logistics Agency issued a $22,959.40 delivery order to AmerisourceBergen Drug Corp on February 18, 2026, for ADDYI 100MG tablets. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and running through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs worldwide. Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for $8,935.35 to supply Addyi 100 mg tablets (30-count units), with completion on March 6, 2026.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA.</p>
- The Defense Logistics Agency issued a $42,077.18 delivery order to Amerisourcebergen Drug Corp on February 11, 2026, for supply of ADDYI 100 mg tablets (30-count units). The order is a call against Amerisourcebergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical commodities to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order is firm...
- <p>The Defense Logistics Agency issued a $9,544.04 delivery order to AmerisourceBergen Drug Corp on February 20, 2026, for ADDYI 100 mg tablets (flibanserin), 30-count units, with an ultimate completion date of February 23, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside used.</p>
- <p>The Defense Logistics Agency issued a $6,116.22 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for ADDYI 100 mg tablets (30-count units). The order is issued under the company's parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026.</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an ultimate completion date of February 6, 2026. No set-aside was used.</p>
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F5AKDDelivery Order
The Defense Logistics Agency issued a $12,895.06 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for ADDYI (flibanserin) 100 mg tablets, 30-count units, under a firm fixed-price arrangement. Place of performance is Conshohocken, PA. Ultimate completion date is March 9, 2026. This is a non-set-aside order. The parent vehicle is the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which authorizes supply of pharmaceutical products and medical commodities to support military healthcare programs globally.
Generated 6/4/26, 11:44 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 3/5/26 |